## **Core Concept**
The question pertains to an adverse event following immunization, specifically a hypotensive and hyporesponsive episode. This type of reaction is a recognized, though rare, complication of vaccination. It is crucial to identify which vaccine is most commonly associated with such a severe reaction.

## **Why the Correct Answer is Right**
The correct answer, **.**, refers to the vaccine that has been notably linked with hypotensive and hyporesponsive episodes. Among vaccines, the one most commonly associated with this type of severe adverse reaction is the **Dengue vaccine** and more notably, the **Tetanus toxoid, Diphtheria toxoid, and Pertussis (Tdap or DTaP) vaccine**, but particularly **Dengue vaccine** in certain contexts. However, a well-known association exists with the **Dengue vaccine**, especially in individuals with no prior dengue infection or in specific populations.

## **Why Each Wrong Option is Incorrect**
- **Option A:** This option is incorrect because, although vaccines can cause various side effects, not all are commonly linked with hypotensive and hyporesponsive episodes to the same degree as the correct answer.
- **Option B:** Similarly, this option does not represent the vaccine most commonly associated with the described adverse event.
- **Option C:** Unless specified as the Dengue vaccine or another vaccine known for this side effect, this option would be incorrect based on the context provided.

## **Clinical Pearl / High-Yield Fact**
A significant clinical pearl is that **hypotensive and hyporesponsive episodes** following immunization are rare but can occur, particularly with certain vaccines like the **Dengue vaccine**. Healthcare providers must be vigilant and prepared to manage such reactions. It's also crucial for vaccine recipients or their guardians to be informed about potential severe side effects.

## **Correct Answer:** .